This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. rose 3.8% to $7.47 on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.3% to 40,669.36 and the NASDAQ Composite Index falling 0.1% to 17,446.34.
The stock's rise snapped a three-day losing streak.
Corbus Pharmaceuticals Holdings Inc. closed 87.9% short of its 52-week high of $61.90, which the company achieved on July 31st.
The stock outperformed some of its competitors, as Vanda Pharmaceuticals Inc. rose 1.8% to $4.51, Fortress Biotech Inc. rose 1.1% to $1.77, and Viking Therapeutics Inc. rose 3.33% to $28.87.
Trading volume totaled 131,714, compared to the 50-day average of 209,286.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
April 30, 2025 16:35 ET (20:35 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.